These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 17287148)

  • 41. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
    Thomann R; Rossinelli N; Keller U; Tirri BF; De Geyter C; Ruiz J; Kränzlin M; Puder JJ
    Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The metabolic syndrome in young Korean women with polycystic ovary syndrome.
    Park HR; Choi Y; Lee HJ; Oh JY; Hong YS; Sung YA
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S243-6. PubMed ID: 17610984
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Omental adipose tissue overexpression of fatty acid transporter CD36 and decreased expression of hormone-sensitive lipase in insulin-resistant women with polycystic ovary syndrome.
    Seow KM; Tsai YL; Hwang JL; Hsu WY; Ho LT; Juan CC
    Hum Reprod; 2009 Aug; 24(8):1982-8. PubMed ID: 19423542
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome.
    Toscani M; Migliavacca R; Sisson de Castro JA; Spritzer PM
    Metabolism; 2007 Jul; 56(7):992-7. PubMed ID: 17570263
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of oral fat and glucose tolerance test on serum lipid profile, apolipoprotein, and CRP concentration, and insulin resistance in patients with polycystic ovary syndrome.
    Bahceci M; Aydemir M; Tuzcu A
    Fertil Steril; 2007 Jun; 87(6):1363-8. PubMed ID: 17362944
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Polycystic ovarian syndrome incidence in young women with non-alcoholic fatty liver disease].
    Ciotta L; Pagano I; Stracquadanio M; Formuso C
    Minerva Ginecol; 2011 Oct; 63(5):429-37. PubMed ID: 21926952
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Overexpression of the phosphoprotein enriched in diabetes gene product (Ped/pea-15) in women with polycystic ovary syndrome.
    Savastano S; Orio F; Palomba S; Cascella T; Manguso F; Lupoli GA; Formisano P; Lombardi G; Colao A; Beguinot F; Valentino R
    Clin Endocrinol (Oxf); 2007 Oct; 67(4):557-62. PubMed ID: 17590172
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults.
    Kim HJ; Kim HJ; Lee KE; Kim DJ; Kim SK; Ahn CW; Lim SK; Kim KR; Lee HC; Huh KB; Cha BS
    Arch Intern Med; 2004 Oct; 164(19):2169-75. PubMed ID: 15505132
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased serum advanced glycation end-products is a distinct finding in lean women with polycystic ovary syndrome (PCOS).
    Diamanti-Kandarakis E; Katsikis I; Piperi C; Kandaraki E; Piouka A; Papavassiliou AG; Panidis D
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):634-41. PubMed ID: 18363886
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum ghrelin level in women with polycystic ovary syndrome and its relationship with endocrine and metabolic parameters.
    Mitkov M; Pehlivanov B; Orbetzova M
    Gynecol Endocrinol; 2008 Nov; 24(11):625-30. PubMed ID: 19031219
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women.
    Alvarez-Blasco F; Botella-Carretero JI; San Millán JL; Escobar-Morreale HF
    Arch Intern Med; 2006 Oct; 166(19):2081-6. PubMed ID: 17060537
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease.
    Targher G; Bertolini L; Scala L; Cigolini M; Zenari L; Falezza G; Arcaro G
    Nutr Metab Cardiovasc Dis; 2007 Sep; 17(7):517-24. PubMed ID: 16928437
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis.
    Polyzos SA; Goulis DG; Kountouras J; Mintziori G; Chatzis P; Papadakis E; Katsikis I; Panidis D
    Hormones (Athens); 2014; 13(4):519-31. PubMed ID: 25402369
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease.
    Wong VW; Hui AY; Tsang SW; Chan JL; Wong GL; Chan AW; So WY; Cheng AY; Tong PC; Chan FK; Sung JJ; Chan HL
    Aliment Pharmacol Ther; 2006 Oct; 24(8):1215-22. PubMed ID: 17014580
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Metabolic syndrome is associated with greater histologic severity, higher carbohydrate, and lower fat diet in patients with NAFLD.
    Kang H; Greenson JK; Omo JT; Chao C; Peterman D; Anderson L; Foess-Wood L; Sherbondy MA; Conjeevaram HS
    Am J Gastroenterol; 2006 Oct; 101(10):2247-53. PubMed ID: 17032189
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatic steatosis in young lean insulin resistant women with polycystic ovary syndrome.
    Markou A; Androulakis II; Mourmouris C; Tsikkini A; Samara C; Sougioultzis S; Piaditis G; Kaltsas G
    Fertil Steril; 2010 Mar; 93(4):1220-6. PubMed ID: 19171337
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening women with polycystic ovary syndrome for metabolic syndrome.
    Dokras A; Bochner M; Hollinrake E; Markham S; Vanvoorhis B; Jagasia DH
    Obstet Gynecol; 2005 Jul; 106(1):131-7. PubMed ID: 15994628
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes.
    Lautamäki R; Borra R; Iozzo P; Komu M; Lehtimäki T; Salmi M; Jalkanen S; Airaksinen KE; Knuuti J; Parkkola R; Nuutila P
    Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E282-90. PubMed ID: 16478772
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nonalcoholic fatty liver disease in women with polycystic ovary syndrome.
    Cerda C; Pérez-Ayuso RM; Riquelme A; Soza A; Villaseca P; Sir-Petermann T; Espinoza M; Pizarro M; Solis N; Miquel JF; Arrese M
    J Hepatol; 2007 Sep; 47(3):412-7. PubMed ID: 17560682
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nonalcoholic fatty liver disease is associated with insulin resistance in a young Hispanic population.
    Perez M; Gonzáles L; Olarte R; Rodríguez NI; Tabares M; Salazar JP; Jaimes S; García RG; López-Jaramillo P
    Prev Med; 2011 Feb; 52(2):174-7. PubMed ID: 21147154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.